Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancer

Abstract Background Esophageal cancer (EC) is the leading cause of cancer‐related mortality worldwide. The underlying genetic risk factors remain unclear. The association between gene growth hormone receptor (GHR) and phospholipase C epsilon 1 (PLCE1) polymorphisms and the EC risk were identified in...

Full description

Bibliographic Details
Main Authors: Rong Wang, Lining Si, Derui Zhu, Guoping Shen, Qifu Long, Yanli Zhao
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.1474
_version_ 1797300979694043136
author Rong Wang
Lining Si
Derui Zhu
Guoping Shen
Qifu Long
Yanli Zhao
author_facet Rong Wang
Lining Si
Derui Zhu
Guoping Shen
Qifu Long
Yanli Zhao
author_sort Rong Wang
collection DOAJ
description Abstract Background Esophageal cancer (EC) is the leading cause of cancer‐related mortality worldwide. The underlying genetic risk factors remain unclear. The association between gene growth hormone receptor (GHR) and phospholipase C epsilon 1 (PLCE1) polymorphisms and the EC risk were identified in this study. Methods A total of 506 EC cases and 507 controls were included in this research. Two SNPs (rs6898743 of GHR and rs2274223 of PLCE1) were selected and genotyped. The associations between gene polymorphisms and the EC risk were assessed by logistic regression analysis. The databases RegulomeDB, GTEx, and UALCAN were used for functional annotations. Results In the allelic frequencies analysis, the rs6898743 of GHR was associated with decreased susceptibility of EC (OR = 0.83, 95% CI: 0.70–1.00, p = 0.049), while rs2274223 of PLCE1 was associated with increased 0.25‐fold EC risk (OR = 1.25, 95% CI: 1.02–1.53, p = 0.037). The “GC” genotype of rs6898743 was associated with a 0.24‐fold decreased risk of EC under co‐dominant model (OR = 0.76, 95% CI: 0.58–0.99, p = 0.046), and the “GA” genotype of rs2274223 was associated with increased EC risk under co‐dominant model (OR = 1.36, 95% CI: 1.04–1.77, p = 0.023). Using GTEx database, rs2274223 was found to be significant associated with increased PLCE1 expression (p = 4.1 × 10−7) in esophagus muscularis. The UALCAN database demonstrated that the GHR gene was under‐expressed in esophageal cancer tissues (p = 0.017). Conclusion The gene GHR and PLCE1 polymorphisms are associated with EC in the general population and the results need to be verified in future.
first_indexed 2024-03-07T23:14:48Z
format Article
id doaj.art-2d3e6f6fd9604a08b66960af70561c18
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-03-07T23:14:48Z
publishDate 2020-10-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-2d3e6f6fd9604a08b66960af70561c182024-02-21T12:03:04ZengWileyMolecular Genetics & Genomic Medicine2324-92692020-10-01810n/an/a10.1002/mgg3.1474Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancerRong Wang0Lining Si1Derui Zhu2Guoping Shen3Qifu Long4Yanli Zhao5Medical college Qinghai University Xining Qinghai Province ChinaDepartment of Critical‐Care Medicine Affiliated Hospital of Qinghai University Xining Qinghai Province ChinaMedical college Qinghai University Xining Qinghai Province ChinaMedical college Qinghai University Xining Qinghai Province ChinaMedical college Qinghai University Xining Qinghai Province ChinaMedical college Qinghai University Xining Qinghai Province ChinaAbstract Background Esophageal cancer (EC) is the leading cause of cancer‐related mortality worldwide. The underlying genetic risk factors remain unclear. The association between gene growth hormone receptor (GHR) and phospholipase C epsilon 1 (PLCE1) polymorphisms and the EC risk were identified in this study. Methods A total of 506 EC cases and 507 controls were included in this research. Two SNPs (rs6898743 of GHR and rs2274223 of PLCE1) were selected and genotyped. The associations between gene polymorphisms and the EC risk were assessed by logistic regression analysis. The databases RegulomeDB, GTEx, and UALCAN were used for functional annotations. Results In the allelic frequencies analysis, the rs6898743 of GHR was associated with decreased susceptibility of EC (OR = 0.83, 95% CI: 0.70–1.00, p = 0.049), while rs2274223 of PLCE1 was associated with increased 0.25‐fold EC risk (OR = 1.25, 95% CI: 1.02–1.53, p = 0.037). The “GC” genotype of rs6898743 was associated with a 0.24‐fold decreased risk of EC under co‐dominant model (OR = 0.76, 95% CI: 0.58–0.99, p = 0.046), and the “GA” genotype of rs2274223 was associated with increased EC risk under co‐dominant model (OR = 1.36, 95% CI: 1.04–1.77, p = 0.023). Using GTEx database, rs2274223 was found to be significant associated with increased PLCE1 expression (p = 4.1 × 10−7) in esophagus muscularis. The UALCAN database demonstrated that the GHR gene was under‐expressed in esophageal cancer tissues (p = 0.017). Conclusion The gene GHR and PLCE1 polymorphisms are associated with EC in the general population and the results need to be verified in future.https://doi.org/10.1002/mgg3.1474esophageal cancergrowth hormone receptorphospholipase C epsilon 1single nucleotide polymorphisms
spellingShingle Rong Wang
Lining Si
Derui Zhu
Guoping Shen
Qifu Long
Yanli Zhao
Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancer
Molecular Genetics & Genomic Medicine
esophageal cancer
growth hormone receptor
phospholipase C epsilon 1
single nucleotide polymorphisms
title Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancer
title_full Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancer
title_fullStr Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancer
title_full_unstemmed Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancer
title_short Genetic variants in GHR and PLCE1 genes are associated with susceptibility to esophageal cancer
title_sort genetic variants in ghr and plce1 genes are associated with susceptibility to esophageal cancer
topic esophageal cancer
growth hormone receptor
phospholipase C epsilon 1
single nucleotide polymorphisms
url https://doi.org/10.1002/mgg3.1474
work_keys_str_mv AT rongwang geneticvariantsinghrandplce1genesareassociatedwithsusceptibilitytoesophagealcancer
AT liningsi geneticvariantsinghrandplce1genesareassociatedwithsusceptibilitytoesophagealcancer
AT deruizhu geneticvariantsinghrandplce1genesareassociatedwithsusceptibilitytoesophagealcancer
AT guopingshen geneticvariantsinghrandplce1genesareassociatedwithsusceptibilitytoesophagealcancer
AT qifulong geneticvariantsinghrandplce1genesareassociatedwithsusceptibilitytoesophagealcancer
AT yanlizhao geneticvariantsinghrandplce1genesareassociatedwithsusceptibilitytoesophagealcancer